Research Management Group (RMG)

Pfizer Center for Therapeutic Innovation (CTI)
Request for Translational Proposals: Biotherapeutic Targets

**Funding opportunity for Stanford faculty with PI eligibility and CE faculty (with an approved PI waiver obtained prior to the pre-proposal submission).

Pre-proposals are requested for translational proposals involving biotherapeutic targets: large molecules: antibodies, proteins, fusion proteins, antibody conjugates in the following therapeutic areas: oncology, Inflammation and Immunology, Cardiovascular and metabolic diseases, Neuroscience, Rare diseases (see descriptions below >>).


The fall 2017 deadline has passed. This webpage is for your reference only.

# of applicants: unlimited numbers of pre-proposals are permitted.

 

Purpose:
CTI: an innovative Pfizer program https://www.pfizercti.com/ that partners with leading academic medical centers and foundations nationwide to accelerate the translation of novel targets to the clinic. CTI seeks to identify and partner novel targets with the goal of identifying new compounds and accelerate drug development from validated target to proof-of-mechanism in humans.

A partnership with CTI may include collaborative use of Pfizer’s technologies, publishing rights, and financial awards in the form of milestone and royalty payments for successful programs, in addition to providing appropriate funds for carrying out the collaborative work.

(*Note: Stanford University has an agreement in place with CTI.)




Amount of funding: not specified.
The term can range from 1 to 5 years.
Per the pre-negotiated terms on the agreement Stanford University has with Pfizer CTI, CTI will provide full IDC reimbursement.

 

Timeline:
Internal pre-proposal deadline:  Monday, Oct. 16, 2017, 5 p.m. (see pre-proposal submission guidelines below)
Jeanne Heschele will submit the pre-proposals via CTI Pfizer online submission portal by Oct. 20th.
If invited to submit a full proposal:
PIs will need to work with their Research Process Manager (RPM) (RPM dept. assignments >>).

 

Guidelines:
This RFP is not on the sponsor's website.
Download a Word document containing the pre-proposal template >>  word


Eligibility:


Selection process clarification:

 

 

Therapeutic Areas of Interest-Fall 2017

 

What they look for:

 




INTERNAL PRE-PROPOSAL SUBMISSION GUIDELINES:


By Monday, Oct. 16, 2017, 5 p.m., please submit one PDF file containing the following in the order listed below via email attachment to:

Please read-message from OTL: Your pre-proposal should not contain any confidential information, as Pfizer will not treat the pre-proposal as confidential. Disclosure of confidential intellectual property in a pre-proposal may jeopardize your ability to protect such intellectual property.

Jeanne Heschele
Research Management Group
jheschele@stanford.edu
650-245-2351

File name: Last name_Pfizer_CTI_Fall_2017.pdf

Institutional representatives: you do not have to submit your pre-proposals through your RPM/RMG or your OSR contract/grant officer for their approval. You can submit your pre-proposal directly to Jeanne. If subsequently invited to submit a full proposal, then you would work with your RPM/RMG or OSR. Exception: CE faculty must submit a CE faculty PI waiver through their RPM 1-2 weeks prior to the Oct. 16th deadline (see below**)

1) Pre-proposal (2-3 pages)
Download the Pre-Proposal template word document
Include the completed pre-proposal in the PDF file to be sent to Jeanne Heschele.
(Reminder-only projects with Large Molecules: antibodies, proteins, peptides, ADCs, fusion proteins, are eligible.)


2) NIH Biosketch for PI and Co-PI(s)

3) CE faculty only**: please send a separate PDF file to Jeanne Heschele at jheschele@stanford.edu containing your approved CE faculty PI waiver request by the Oct. 16th deadline as well.Reminder: CE faculty you must submit your CE faculty PI waiver request >> through your Research Process Manager (RPM in RMG >>) at least 1-2 weeks prior to the pre-proposal deadline






 

Footer Links: